Author:
Maxwell Colleen J.,Vu Mary,Hogan David B.,Patten Scott B.,Jantzi Micaela,Kergoat Marie-Jeanne,Jetté Nathalie,Bronskill Susan E.,Heckman George,Hirdes John P.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference69 articles.
1. World Health Organization and Alzheimer’s Disease International. Dementia: a public health priority. Geneva: World Health Organization; 2012.
2. Jakobsen M, Poulsen PB, Reiche T, et al. Costs of informal care for people suffering from dementia: evidence from a Danish survey. Dement Geriatr Cogn Dis Extra. 2011;1(1):418–28.
3. Hill J, Fillit H, Thomas SK, et al. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer’s disease and other dementias. Pharmacoeconomics. 2006;24(3):265–80.
4. Leicht H, Heinrich S, Heider D, et al. Net costs of dementia by disease stage. Acta Psychiatr Scand. 2011;124(5):384–95.
5. Smetanin P, Kobak P, Briante C, Stiff D, Sherman G, Ahmad S. Rising tide: the impact of dementia in Canada 2008 to 2038. Toronto: Alzheimer Society of Canada; 2009.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献